Suntrust Banks’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $3.65M | Sell |
36,637
-5,540
| -13% | -$551K | 0.02% | 416 |
|
2019
Q2 | $4.6M | Sell |
42,177
-5,332
| -11% | -$582K | 0.02% | 364 |
|
2019
Q1 | $5.31M | Buy |
47,509
+5,131
| +12% | +$574K | 0.03% | 322 |
|
2018
Q4 | $4.09M | Sell |
42,378
-20,604
| -33% | -$1.99M | 0.02% | 349 |
|
2018
Q3 | $7.68M | Buy |
62,982
+23,176
| +58% | +$2.83M | 0.04% | 262 |
|
2018
Q2 | $4.37M | Sell |
39,806
-9,486
| -19% | -$1.04M | 0.02% | 346 |
|
2018
Q1 | $5.26M | Buy |
49,292
+17,127
| +53% | +$1.83M | 0.03% | 296 |
|
2017
Q4 | $3.43M | Sell |
32,165
-28,501
| -47% | -$3.04M | 0.02% | 351 |
|
2017
Q3 | $6.75M | Buy |
60,666
+14,277
| +31% | +$1.59M | 0.04% | 252 |
|
2017
Q2 | $4.79M | Sell |
46,389
-2,934
| -6% | -$303K | 0.03% | 305 |
|
2017
Q1 | $4.82M | Buy |
49,323
+4,071
| +9% | +$398K | 0.03% | 293 |
|
2016
Q4 | $4M | Buy |
45,252
+30,444
| +206% | +$2.69M | 0.02% | 337 |
|
2016
Q3 | $1.43M | Sell |
14,808
-1,962
| -12% | -$189K | 0.01% | 662 |
|
2016
Q2 | $1.44M | Buy |
16,770
+5,634
| +51% | +$482K | 0.01% | 609 |
|
2016
Q1 | $967K | Buy |
11,136
+4,476
| +67% | +$389K | 0.01% | 715 |
|
2015
Q4 | $750K | Buy |
6,660
+948
| +17% | +$107K | ﹤0.01% | 808 |
|
2015
Q3 | $576K | Buy |
5,712
+603
| +12% | +$60.8K | ﹤0.01% | 825 |
|
2015
Q2 | $628K | Buy |
5,109
+684
| +15% | +$84.1K | ﹤0.01% | 783 |
|
2015
Q1 | $504K | Buy |
4,425
+183
| +4% | +$20.8K | ﹤0.01% | 827 |
|
2014
Q4 | $427K | Sell |
4,242
-3,735
| -47% | -$376K | ﹤0.01% | 857 |
|
2014
Q3 | $726K | Sell |
7,977
-6,204
| -44% | -$565K | 0.01% | 812 |
|
2014
Q2 | $1.21M | Sell |
14,181
-22,758
| -62% | -$1.95M | 0.01% | 615 |
|
2014
Q1 | $2.91M | Sell |
36,939
-450
| -1% | -$35.5K | 0.01% | 573 |
|
2013
Q4 | $2.83M | Buy |
37,389
+33,549
| +874% | +$2.54M | 0.01% | 577 |
|
2013
Q3 | $268K | Hold |
3,840
| – | – | ﹤0.01% | 1530 |
|
2013
Q2 | $222K | Buy |
+3,840
| New | +$222K | ﹤0.01% | 1547 |
|